Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats

Transplantation Proceedings

Volumn 43, Issue 5, 2011, Pages 1450-1455

  Li, Y ^a   Zhang, P J ^a   Jin, C ^a   Zhou, B ^a   Liu, X Y ^a   Tao, L D ^a   Feng, M ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; DEFEROXAMINE MESYLATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MALONALDEHYDE; TRIACYLGLYCEROL LIPASE;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER PERFUSION; LIVER TRANSPLANTATION; MICROSCOPY; NONHUMAN; PANCREAS; PANCREAS DISEASE; PANCREAS ISCHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY;

AMYLASES; ANIMALS; DEFEROXAMINE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LIPASE; LIVER TRANSPLANTATION; MALONDIALDEHYDE; MICROSCOPY; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 79959433994     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.176     Document Type: Article

References (40)

1. S. Patel, H.L. Pachter, and H. Yee Topical hepatic hypothermia attenuates pulmonary injury after hepatic ischemia and reperfusion J Am Coll Surg 191 2000 650
2. K. Meyer, M.F. Brown, and G. Zibari ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure J Pediatr Surg 33 1998 350
3. D. Mu, Y.S. Chang, and Z.S. Vexler Hypoxia-inducible factor 1α and erythropoietin upregulation with deferoxamine salvage after neonatal stroke Experimental Neurology 195 2005 407
4. G.T. Drugas, C.N. Paidas, and A.M. Yahanda Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion Circ Shock 34 1991 278
5. B. Halliwell Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol Med 7 1989 645
6. C. Palmer, R.L. Roberts, and C. Bero Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats Stroke 25 1994 1039
7. J. Varani, M.K. Dame, M. Diaz, and L. Stoolman Deferoxamine interferes with adhesive functions of activated human neutrophils Shock 5 1996 395
8. L.M. Colletti, D.G. Remick, and D.A. Campbell Jr Desferal attenuates TNF release following hepatic ischemia/reperfusion J Surg Res 57 1994 447
9. F.W. Sellke, T. Shafique, and D.L. Ely Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals Circulation 88 1993 395
10. A. Stamler, S.V. Wang, and D.E. Aguirre Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation Ann Thorac Surg 64 1997 460
11. K. Morita, K. Ihnken, and G.D. Buckberg Studies of hypoxemic/ reoxygenation injury: without aortic clamping IV role of the iron-catalyzed pathway: deferoxamine J Thorac Cardiovasc Drug 110 1995 1182
12. R.W. Illes, N.A. Silverman, and I.B. Krukenkamp Amelioration of post-ischemic stunning by deferoxamine-blood cardioplegia Circulation 80 1989 30
13. D.E. Euler Role of oxygen-derived free radicals in canine reperfusion arrhythmias Am J Physiol 268 1995 H295
14. A. Stamler, S.V. Wang, and D.E. Aguirre Effects of pentastarch deferoxamine conjugate on lung injury after cardiopulmonary bypass Circulation 94 1996 358
15. P. Menasche, H. Antebi, and L.G. Alcindor Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans Circulation 82 1990 390
16. R. Ferreira, M. Burgos, and J. Milei Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium J Thorac Cardiovasc Surg 100 1990 708
17. D.A. De Boer, and R.E. Clark Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity Ann Thorac Surg 53 1992 412
18. H.F. Zhao, and J. Zhou Establishment of an orthotopic autologous liver transplantation model with bile ducts ischemia-reperfusion injury in rats Acad J Sec Mil Med Univ 27 2006 429
19. J. Cheng, P.-J. Zhang, and X.-M. Wu Impact of hypoxic preconditioning on apoptosis and its possible mechanism in orthotopic liver autotransplantation in rats Hepatobiliary Pancreat Dis Int 8 2009 40
20. K. Meyer, M.F. Brown, and G. Zibari ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure J Pediatr Surg 33 1998 350
21. J.V. Conte Jr, N.M. Katz, and M.L. Foegh Iron chelation therapy and lung transplantation Effects of deferoxamine on lung preservation in canine single lung transplantation J Thorac Cardiovasc Surg 101 1991 1024
22. M. Vairetti, A. Ferrigno, and R. Bertone Apoptosis vs. necrosis: glutathione-mediated cell death during rewarming of hepatocytes Biochim Biophys Acta 1740 2005 367
23. U. Rauen, U. Kerkweg, and D. Weisheit Cold induced apoptosis of hepatocytes: mitochondrial permeability transition triggered by nonmitochondrial chelatable iron Free Radic Biol Med 35 2003 1664
24. D.P. Sarco, J. Becker, and C. Palmer The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain Neuroscience Letters 282 2000 113
25. S. Liachenko, P. Tang, and Y. Xu Deferoxamine improves early post resuscitation reperfusion after prolonged cardiac arrest in rats J Cereb Blood Flow Metab 23 2003 574
26. C. Polat, C. Tokyol, and A. Kahraman The effects of desferrioxamine and quercetin on hepatic ischemia-reperfusion induced renal disturbance Acta Chir Belg 106 2006 68
27. C. Tokyol, S. Yilmaz, and A. Kahraman The effects of desferrioxamine and quercetin on liver injury induced by hepatic ischaemia-reperfusion in rats Exp Neurol 195 2005 407
28. N. Arkadopoulos, C. Nastos, and K. Kalimeris Iron chelation for amelioration of liver ischemia-reperfusion injury Hemoglobin 34 2010 265
29. A. Dendorfer, M. Heidbreder, and T. Hellwig-Brgel Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals Free Radical Biol Med 38 2005 117
30. T. Date, S. Mochizuki, and A.J. Belanger Expression of constitutively stable hybrid hypoxia inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury Am J Physiol Cell Physiol 288 2005 C314
31. M. Bergeron, J.M. Gidday, and A.Y. Yu Role of hypoxia-inducible factor-1 in hypoxia induced ischemic tolerance in neonatal rat brain Ann Neurol 48 2000 285
32. G.L. Semenza Surviving ischemia: Adaptive responses mediated by hypoxia inducible factor 1 J Clin Invest 106 2000 809
33. N.C. Chi, and J.S. Karliner Molecular determinants of responses to myocardial ischemia/reperfusion injury: Focus on hypoxia-inducible and heat shock factors Cardiovasc Res 61 2004 437
34. P. Dobsák, J. Siegelova, and J.E. Wolf Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model Pathophysiology 9 2002 27
35. W.H. Tang, S. Wu, and T.M. Wong Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart Free Radic Biol Med 45 2008 602
36. N. Balogh, F. Krausz, and P. Lévai Effect of deferoxamine and L-arginine treatment on lipid peroxidation in an intestinal ischaemia- reperfusion model in rats Acta Vet Hung 50 2002 343
37. P.C. Marin, M.J. Im, and J.A. Girotto Effects of hydroxyethyl-starch- bound deferoxamine on ischemia/reperfusion injury in chronic nerve compression J Reconstr Microsurg 14 1998 485
38. T. Freret, S. Valable, and L. Chazalviel Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat Eur J Neurosci 23 2006 1757
39. I.A. Paraskevaidis, K. Efstathios, Iliodromitis, and Demetrios Vlahakos Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance European Heart Journal 26 2005 263
40. Y. Zhu, L. Zhang, and J.M. Gidday Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance J Ocul Pharmacol Ther 24 2008 527